Monday, March 11, 2013

Hints of Gentiva's 2012 Executive Pay


StrangeTony,

While Gentiva employees received no raises in 2012 and long term stockholders remain in the red, the first hint of executive compensation came in the company's 10-K.

Equity based compensation rose slightly in 2012. For the year ended December 31, 2012, the Company recorded equity-based compensation expense, as calculated on a straight-line basis over the vesting periods of the related equity instruments, of $7.6 million as compared to $7.5 million for the corresponding period of 2011. 
Performance cash awards could also be gleaned:

For 2012, the Company granted performance cash awards of approximately $4.8 million, with 50 percent of the award based on a 2012 diluted earning per share target and 50 percent of the award based on a 2014 diluted earnings per share target, subject to certain adjustments, with the awards expected to fully vest at the end of 2014. The performance cash awards based on 2012 diluted earnings per share target will be paid at 85 percent of target. 
I could find no reference to performance cash awards in any of the company's last three 10-K's.  However, their annual proxy statements did list performance cash awards.  The last award given was in January 2011 and totaled roughly $1.5 million.  The $4.8 million is a 220% increase.

The SEC report mentions Rod Windley's new role as Executive Chairman, but gave no information on his compensation, now that he's working full time for Gentiva.

The company's Proxy Statement should be out in two weeks.  It will have a detailed breakdown of how executive's made out on the backs of Gentiva's workers.

Anonymous

Friday, March 8, 2013

Management Creates Darkness

StrangeTony,

I came across this survey and it fits with what we've been sharing, you at Generic Hospice and me at Gentiva.

U.S. corporate executives paint a bleak picture of the workplace, full of dolts and drones.

Workers lack communication, collaboration, critical thinking and creative skills executives say, according to a recent survey by the American Management Association. Turns out, bosses aren't too excited about their underlings' abilities, a prospect they're getting more worried about considering such skills will be more important amid a changing business landscape, they say.

The number of executives rating their employees as below average increased across all four areas since the survey was last taken in 2010. Almost 20 percent of workers lack at least average creative skills, according to executives.

American leaders frequently pit workers against one another, sloughing off the bottom 5-10%.  This internal competition comes at a price.

Rather than building character, competition sabotages self-esteem and ruins relationships. 

Add leaders' over-reliance on extrinsic reward programs, which kill intrinsic motivation and management has created the very thing it abhors.

The more an organization relies on incentives, the worse things get.

Leaders fail to recognize their dissatisfaction is of their making.  While the overall situation is bleak, Gentiva's is bleaker.   

Gentiva Hospice employees aren't communicated with.  For there to be an opportunity for collaboration, the company would need to seek input.  Gentiva dropped the employee survey two years ago.  There's no sign of its return.  It went the way of raises.

As for critical thinking skills, those are not desired in a directive, top down company.  "Yes" is what they expect to hear.  Creative skills are also superfluous.  Anything "created" must be submitted to corporate for approval.

Anonymous

Sunday, March 3, 2013

Gentiva Management: Insider Stock Sales

StrangeTony,

Gentiva executives sold stock during the last quarter of 2012 and first quarter of 2013.  New Executive Chairman Rod Wndley sold 230,000 shares for proceeds of nearly $2.5 million.  This is hardly a vote of confidence from Gentiva's expected turnaround chief.

Hospice Division President Jeff Shaner flipped 28,000 option shares, paying $5.16 per share and selling for an average $11.05.  Shaner made $164,000 with his option redemption.

On insider buys vs. sells, the metric shows zero buys and fifteen sales.   Gentiva CEO Tony Strange failed to mention this in their Q4 and year end analysts call.   Maybe analysts will catch it before the next investor presentation.

Barclays Global Healthcare Conference -- Miami, Florida at 4:45 p.m. ET on Tuesday, March 12, 2013

Might Tony Strange have guidance on the impact of sequestration in this call?   One analyst gave Tony a hard time over his sequestration caginess.  Will she pop up in the Q & A?

While analysts missed insider sales, Seeking Alpha caught them. Gentiva made their post "Three Stocks with Recent Intensive Insider Selling."  The Gentiva analysis summary states:

There have been four insider sell transactions and there have not been any insider buy transactions during the last 30 days. The stock is trading at a P/E ratio of 11.89 and a forward P/E ratio of 7.60. The company has a book value of $7.63 per share. There are two analyst buy ratings, six neutral ratings and one sell rating, with an average target price of $8.88. Before entering short this stock, I would like to get a bearish confirmation from the Point and Figure chart.  Three main reasons for the proposed short entry are negative revenue growth, bearish analyst target prices and the intensive insider selling activity.  
 What news will break next?  Will the company speak to how it plans to weather the 2% Medicare hospice cut from sequestration?  Will their expected March Def 14a reveal executive incentive compensation for 2012?  When will the company let employees know if any raise can be expected in 2013? 

While those at the bottom wait for crumbs to fall from Atlanta, Gentiva executives stand enriched.  They'd have it no other way.

Anonymous

Wednesday, February 27, 2013

Generic Beliefs

I believe in a kind of war
that overcomes each win.

I believe in a kind of pass
that brings hope and comfort to lies.

I believe in a kind of mir
that is lo. 

Generic Hospice - Metric Centered, Dehumanized

Wednesday, February 20, 2013

Suspended


Maybe it was a compliment
Getting _____  ______   ______  _______ (insert your punishment here)

Maybe an affirmation from God's heart
Getting scolded and rebuffed
     For standing in the stead of the helpless and their helpers.

"It was inappropriate."
And so it was!  But only from the rarefied roost
of the elite guardians of The Image
Anything for The Image.

But from the humbler, simpler stance
of the helpless and their helpers
The voice that rises to raise the right questions
is always the right remedy for the right malady
Always the empathic hand that removes the thorn
     from the festering paw.

What's the difference?
It's in the direction.
The self-absorbed and self-promoters
Live on a one-way street of Thou shalt give to me
But those whose eyes take in the needs of others
Find their truth in serving.

So maybe it was a compliment
to be summoned by the court
A backhanded affirmation from the Lowly and their Liege
The Rulers think they won!
But when the world is turned upside down,
The spurned, who fell, are rising.

Contributed by Generic Hospice Staffer
Messenger - StrangeTony

Saturday, February 16, 2013

Gentiva: Where M is for Mediocre


StrangeTony,

Your coworker spoke deep truth on changes in IDT at Generic Hospice.  I offer a bit of same (hopefully) in return regarding Gentiva.  I intersperse my lament with words from Gentiva CEO Tony Strange:

I can't say I was excited about the way Gentiva leaders decimated our hospice's clinical services. Over a period of months they instituted programs that eliminated every special, distinctive, unique thing we did for our patients. Gentiva corporate dismantled what made us the standard of excellence in our community.

"We have four pillars for growth. One, we continue to invest in our clinical delivery system... Two, continue to expand our referral base through investment in our sales organization...Three, realize Home Health/Hospice synergies (Positioning Gentiva to be a care transition company, to get patients into the most cost effective setting)…. Four, grow through strategic acquisitions (Positioning ourselves,looking to de-lever by paying down debt/growing earnings, look at opportunistic acquisitions)."--Tony Strange, Gentiva CEO at 2013 JP Morgan Healthcare Conference.

I saw earnings grow through employee turnover.  It bothered me that many of my peers worked long hours covering for two positions for months at a time and the company did nothing to thank them, much less reward them for their burdensome labor. They were salaried. There was no additional compensation. My peers worked the hours needed "to get the job done." It mattered not to the higher ups that one person was doing two jobs.  That bolstered EBDITA.

When someone does two jobs they can't do both well. When mistakes were made, as any competent leader could predict, management hammered them. Write ups, counselings, what's the matter with you, why can't you think, I'll teach you, now get back to work and stay until everything's done to my specific direction!   While it may have been couched in more socially appropriate wording, the message was clear.

"Home health and hospice offers a cost effective alternative to providing care for the aging demographic."--Tony Strange, Gentiva CEO 

Things weren't great, but I maintained my intrinsic motivation to help others do sacred work, that is until....

"We have a very strong density in Certificate of Need states, which creates a barrier to entry. We have a very strong presence in CON states."--Tony Strange, Gentiva CEO 

...they judged me.  I could expound on technical flaws regarding the annual performance evaluation, how it wasn't based on my job description, how it covered events after the evaluation period or how I was held accountable for things not within my control. Those bothered me, but something cut deeper.

Gentiva rammed a stake through my intrinsic desire to do good work, to be part of a team, to contribute to something greater, something sacred. I let their judgment pierce my heart.

I swore I wouldn't let in those corporate bastards. I promised to hold off their reliance on word-parsing lawyers, tight-fisted bean counters, and orange-tinted, white-toothed marketers. This troika set the corporate agenda which repeatedly unbalanced our site. Even with our hospice badly listing, I thought I could hold on, hang in there, even be a positive, counterbalancing force.

"Average aged of our patient is 79 years old. They have multiple co-morbid diagnoses and are on 10 or more medications."--Tony Strange, Gentiva CEO 

We used to deliver medications to the patient's home. The company instituted a new formulary which dropped many medications our patients used. Overtime was banned, needing corporate approval before a nurse or chaplain could stay over.

At first, staff ignored corporate directives. When a nurse asked to stay with a dying patient, the common answer, "No Overtime allowed." Nurses, given their professional oath, usually donated their time.

When corporate HR learned this, a pinhead essentially said, "That's not allowed. They can't work overtime without approval and they can't donate their time. Write 'em up. Who's doing it?"

No one answered.

Pinhead,"Warn them, if they do it again they'll be fired!"

"Investment highlights. Demographics are compelling. Our market grows by 10,000 people per day. Patients have skin in the game. We have a seasoned management team. Most of the team have been with me over a decade."--Tony Strange, Gentiva CEO 

This "management team" knows Home Health. They don't know jack squat about Hospice.

How did I allow this crappy company, with its over-reliance on control by extrinsic motivation, to wound my internal desire to make a difference? I struggled with how to move forward ever since I was labeled a "good, solid employee," nothing special.

Funny, the descriptions in the evaluation were highly complimentary. They noted the many outstanding things I'd accomplished. If those words were the only thing on the page, I'd have been content. No, the company had to collapse me into a summary rating (High, Medium or Low).

They ranked me M for mediocre, effectively damning me with faint praise. They collapsed a year's worth of hard work,where I'd done many things outside my job description, into one solitary letter of the alphabet. It seemed I was downgraded for not doing even more outside my job, despite putting in long hours, with great impact.

The evaluation came with nothing. I received no raise, no bonus, no gift card, no anniversary present, not even a cheap Chinese pen or crappy mouse pad embossed with the company logo.

I felt I gave my all. I didn't see how I could've worked harder or been more effective. I would've been happy to not had their judgment, pro or con.  That's not why I do the work.

Yet, they gave it and I made the mistake of listening.  Gentiva's judgment acted like an invasive cancer on my heart. It couldn't see a sliver of what I'd contributed, much less the whole. I had to remind my evaluator of the many things I'd done specifically to help them and our site, most of which were not in my job description. What the company couldn't see, it couldn't appreciate.

I did those things because I wanted to, not for recognition. So why is this bothering me so much now? Why would I expect an out of balance company to appreciate human respect and dignity? Maybe I don't want to become mediocre, like the company itself.

"Closed or sold about 59 locations... Took a lot of cost actions end of last year, took out additional regional/area costs, corporate back office costs... Home health continues to run very strong... Hospice has been challenged... Get after growth with sales initiatives, better trained sales people, more salespeople, more feet on the ground. Put a new leader in April in Hospice sales organization. No different than what we went through with home health two years ago. Looking forward to 2013 and getting hospice back on track." Eric Stusser, Gentiva CFO at 2013 JP Morgan Healthcare Conference
Anonymous 

Addendum:  It's been two years and the second evaluation went much like the first.  While my co-workers say they've never had service this good, my boss focused on a handful of things I hadn't done.  It's sad when the annual evaluation requires a coat of armor to survive.  Toxic management is alive and unwell at Gentiva. 

Two Contrasting Images: IDT Past & Present

Anonymous,

A coworker crafted this after our last IDT.  

Among the changes experienced in hospice philosophy in recent years, as hospice work increasingly come under the influence of corporate business and its marketing emphasis, is the change in image of the interdisciplinary team meeting, or IDT.  

In former times, the IDT meeting was something like a blue collar Laundromat.  Yes, it was professional, organized and to the point.  But there was an understanding that each person was bringing in some dirty laundry, and that it would be sorted out, thrown into the washing machines, and that this would involve some noise, some agitation, some movement and chaos, on the way to ending up with clean, dried, and folded items, ready for the next day's jobs.  The way the soiled clothing arrived and the way the finished product ended up, presumed and welcomed a sometimes rough and tumble process in between.

In more recent times, and increasingly, there are different forces at work, and an image that might express the change in IDT is that of the finale of a Beauty Pageant.  The unspoken but strongly implied expectation is that there is to be a show of excellence and shiny perfection.  The attractive and beautiful surfaces are paraded upon the stage, for all to ooh and ahh.  There is niceness and tidiness from start to finish.  There is a hyper-awareness that the cameras are rolling.  We smile, but with measured propriety.  Our lines are pre-censored, and well rehearsed.  No ad lib comments will be tolerated.  No embarrassing or uncomfortable questions are to be asked.  It's not an earthy process--it's a careful performance.  Contradictory opinions and al challenges will be viewed as crass rebellion, and as undermining the status quo, which is believed to be have been dropped down whole from Corporate heaven.

Beautiful surfaces look impressive.  But I miss the realness, liveliness, and outcomes of the old washateria. 

This speaks volumes in regard to the heart of Generic Hospice.